Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion
Status:
Completed
Trial end date:
2021-08-30
Target enrollment:
Participant gender:
Summary
To investigate whether vaginal isonicotinic acid hydrazide administered before the
levonorgestrel-releasing intrauterine system insertion reduces IUD insertion pain and
difficulty in insertion in adolescents and young women.